Click to Enlarge
Facebook
Twitter
The Financial Times leads on pharmaceuticals giant AstraZeneca drawing up plans to separate the Chinese arm of its global business and list it on the Hong Kong stock exchange – as a way of sheltering the company against mounting geopolitical tensions. The paper observes the moves shows the “significant restructuring” companies could be forced to undertake as they adapt to growing China–US friction. A person briefed on the plans explains to the paper it could insulate the firm from any moves by China to crackdown on foreign companies, by making it more plausibly a Chinese business.

Financial Times Front Page 2nd of February 2026

Emails reveal Peter Mandelson advised Jeffrey Epstein that JPMorgan should pressure the UK over the 2009 bankers’ bonus tax, urging contact with the chancellor. He says he sought to protect jobs and investment. Labour is under pressure to address the revelations.

Read More »

Financial Times Front Page 31st of January 2026

Donald Trump nominated Kevin Warsh to lead the Fed, signalling a firmer stance on inflation. Markets backed the dollar and trimmed expectations of rapid rate cuts. US yields rose while gold fell as investors priced in steadier policy and renewed questions over central bank independence.

Read More »

Financial Times Front Page 30th of January 2026

US immigration agencies under the Trump administration have awarded about $22bn in contracts since July, with Palantir and Deloitte among winners. ICE’s spending has doubled, and donor-linked Fisher Sand & Gravel has gained about $6bn. Deals cover tech, detention and logistics services.

Read More »